SOP ICU-acquired Weakness (Critical-Illness-Polyneuropathie/Critical-Illness-Myopathie)

In dieser Rubrik stellen wir Standard Operating Procedures (SOPs) für häufige, intensivmedizinisch relevante Prozesse vor. Die Form ist eher im Sinne einer Schablone zu verstehen als – durchaus subjektiv gefärbte – Anregung, eigene, auf lokale Gegebenheiten adaptierte stationsinterne SOPs zu entwerfen und zu implementieren.

• Literatur

• 1 Kress JP, Hall JB. ICU-Acquired Weakness and Recovery from Critical Illness. N Engl J Med 2014; 370: 1626-1635
• 2 Brunkhorst F, Axer H. What are the Causes of and how do I treat critical Illness Neuropathy/Myopathy?. In: Deutschman CS, Neligan PJ. eds. Evidence-Based Practice of critical Care. 3rd ed.. Amsterdam: Elsevier; 2020: 208-214.e1
• 3 Hermans G, Van den Berghe G. Clinical review: intensive care unit acquired weakness. Crit Care 2015; 19: 274
• 4 Stevens RD, Dowdy DW, Michaels RK. et al. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med 2007; 33: 1876-1891
• 5 Latronico N, Fenzi F, Recupero D. et al. Critical illness myopathy and neuropathy. Lancet 1996; 347: 1579-1582
• 6 De Jonghe B, Sharshar T, Lefaucheur J-P. et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 2002; 288: 2859-2867
• 7 Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol 2011; 10: 931-941
• 8 Fan E, Cheek F, Chlan L. et al. An official American Thoracic Society Clinical Practice guideline: the diagnosis of intensive care unit-acquired weakness in adults. Am J Respir Crit Care Med 2014; 190: 1437-1446
• 9 Hermans G, Clerckx B, Vanhullebusch T. et al. Interobserver agreement of Medical Research Council sum-score and handgrip strength in the intensive care unit. Muscle Nerve 2012; 45: 18-25
• 10 Grimm A, Günther A, Witte OW. et al. Critical-Illness-Polyneuropathie und Critical-Illness-Myopathie. Med Klin Intensivmed Notfmed 2012; 107: 649-660
• 11 Lacomis D. Electrophysiology of neuromuscular disorders in critical illness. Muscle Nerve 2013; 47: 452-463
• 12 Lefaucheur J-P, Nordine T, Rodriguez P. et al. Origin of ICU acquired paresis determined by direct muscle stimulation. J Neurol Neurosurg Psychiatr 2006; 77: 500-506
• 13 Weber-Carstens S, Koch S, Spuler S. et al. Nonexcitable muscle membrane predicts intensive care unit-acquired paresis in mechanically ventilated, sedated patients. Crit Care Med 2009; 37: 2632-2637
• 14 Bierbrauer J, Koch S, Olbricht C. et al. Early type II fiber atrophy in intensive care unit patients with nonexcitable muscle membrane. Crit Care Med 2012; 40: 647-650
• 15 Grimm A, Teschner U, Porzelius C. et al. Muscle ultrasound for early assessment of critical illness neuromyopathy in severe sepsis. Crit Care 2013; 17: R227
• 16 Khan J, Harrison TB, Rich MM. et al. Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurology 2006; 67: 1421-1425
• 17 Moss M, Yang M, Macht M. et al. Screening for critical illness polyneuromyopathy with single nerve conduction studies. Intensive Care Med 2014; 40: 683-690
• 18 Hermans G, De Jonghe B, Bruyninckx F. et al. Interventions for preventing critical illness polyneuropathy and critical illness myopathy. Cochrane Database Syst Rev 2014; (01) CD006832
• 19 Brunkhorst FM, Engel C, Bloos F. et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358: 125-139
• 20 Brunner R, Rinner W, Haberler C. et al. Early treatment with IgM-enriched intravenous immunoglobulin does not mitigate critical illness polyneuropathy and/or myopathy in patients with multiple organ failure and SIRS/sepsis: a prospective, randomized, placebo-controlled, double-blinded trial. Crit Care 2013; 17: R213